CPYA 4.210 #  X r ??0myodna_A M3x4!?m;z'?YWgP1?K`R$ ?w짃,?67?$ C?5i>9P?X#Z?gYHf?{7?wr?K~?gO~bd?l36? FB:?lUuë?!bV?oI?;ŪA?vFd8?[`B?F4˯0?CO}?tV{? r `??myogenindna_B 1Tj?@*=?@*=?@*=?@*=?@*=?@*=?@*=?@*=?@*=?@*=?1Tj?@*=?1Tj?~D~e?هHJ?e±?H? T ?nߺ??v? myodna ^DLP C:\Origin,FrXXsbinding of MyoD to MCK enhancer ^@? @"@?@l "$$tW3T (? ף= ף= Pd c #ll??(>>__WIPR (  l??(  c #c5fffff?Կ(G>>__WIOTN (  Ifffff?Կ(G I o92 R A  [MyoD] (uM) R B`  anisotropy R   R @ R  "&@%$ R @$$ R   R  P R   R @ R  "&@%$ R @$$ R   R  P R  R  R  R  R  R  myogenindna ^DLP C:\Origin,FrXXsbinding of myogenin to MCK enhancer ^@?@"@?@l "$$W3T (? ף= ף= Pd c # vm̜?333333?(>>__WIPR (  m̜?333333?(  c #c5fffff?Կ(G>>__WIOTN (  Ifffff?Կ(G I o92 R A  [myogenin] (uM) R B`  anisotropy R   R @ R  "&@% $ R @$ $ R   R  P R   R @ R  "&@%$ R @$$ R   R  P R  R  R  R  R  R